Last10K.com

Heat Biologics, Inc. (HTBX) SEC Filing 8-K Material Event for the period ending Friday, June 21, 2019

Heat Biologics, Inc.

HISTORY TOOLS
CIK: 1499543 Ticker: HTBX

View differences made from one to another to evaluate Heat Biologics, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Heat Biologics, Inc..

Continue

Assess how Heat Biologics, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Heat Biologics, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools
Ticker: HTBX
CIK: 1476963
Form Type: 8-K Corporate News
Accession Number: 0001553350-19-000663
Submitted to the SEC: Fri Jun 21 2019 5:20:17 PM EST
Accepted by the SEC: Fri Jun 21 2019
Period: Friday, June 21, 2019
Industry: Pharmaceutical Preparations
Events:
  1. Listing Status

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/htbx/0001553350-19-000663.htm